Scatterplot 5. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Scatterplot 9. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Scatterplot 1. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Scatterplot 6. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Scatterplot 2. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Raw data of this study. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Scatterplot 4. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Scatterplot 3. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Correlation matrix. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Scatterplot 7. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

S1 Raw data - by Dao-Cheng Zhou (20314697)

“…Health behaviors had a more dominant effect compared to health factors. All-cause and CVD mortality gradually decreased with increasing ideal LE8 metrics. …”

CLIC1 accelerates oxidative stress in oxygen and glucose deprivation/reoxygenation (OGD/R)-treated HT22 cells by inhibiting the Nrf2/HO-1 signalling pathway. by Jingtong Xiong (22272139)

“…(d) CCK-8 OD values were decreased after Nrf2/HO-1 inhibition, with lower values observed in the OGD/R+CLIC1 silencing+Nrf2/HO-1 inhibition group than the OGD/R+CLIC1 silencing group. …”

Baseline characteristics of the four groups. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Flow of included patients through the trial. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Cox proportional hazards modeling. by Chao Yang (174810)

“…When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. When the HAR was higher than 0.13, the HAR was not a protective factor for mortality within 28 days after ICU admission. …”

Data Sheet 1_Temperature influences mood: evidence from 11 years of Baidu index data in Chinese provincial capitals.csv by Mengjiao Yin (10995604)

“…Threshold regression analysis was also conducted to identify nonlinear effects.</p>Results<p>The results showed that for every 1°C increase in DMT, search indices for depression, anxiety, and loneliness increased significantly by 22.71%, 18.76%, and 19.59%, respectively (p < 0.01). …”

Data Sheet 1_Efficacy of different pharmaceutical forms of Curcuma longa or curcumin in reducing oral mucositis severity and incidence in cancer patients: a systematic review and m... by Pedro de Padua G. Amatto (20981201)

“…The pooled analysis showed significant reductions in WHO scores and oral pain compared to placebo. …”

Image 1_The efficacy of sequentially comprehensive treatment based on surgery in the treatment of keloids: a retrospective study.jpeg by Kun Yang (19445)

“…</p>Conclusion<p>The sequentially comprehensive treatment based on surgery has a significant curative effect, as well as a low recurrence rate and a low adverse effect rate. …”

Data Sheet 1_Comparative analysis of anthelmintic treatments: impact on liver biomarkers and clinical recovery in sheep with fasciolosis.pdf by Tameru Gedefaw (20759399)

“…Despite the widely use of Triclabendazole (TCBZ), Tetraclozan (TETRA), and Albendazole (ALBE) for treating fasciolosis, their effectiveness remains a significant concern. This study aimed to compare the efficacy of TCBZ, TETRA, and ALBE in treating ovine fasciolosis, with a focus on their effects on both the parasitic infection and associated biochemical parameters. …”

Clinical data of lymphoma patients. by Runlong Lin (20796909)

“…Moreover, the count of patients with abnormal cardiac uptake significantly rose post-treatment. Analyzing changes in uptake patterns, the group displaying abnormal changes exhibited an increase in left atrial diameter and a decrease in left ventricular ejection fraction compared to the group with normal changes. …”